LOCAL DELIVERY OF THERAPEUTIC AGENT TO HEART VALVES
    3.
    发明公开
    LOCAL DELIVERY OF THERAPEUTIC AGENT TO HEART VALVES 审中-公开
    地方税治疗心脏瓣膜MEANS

    公开(公告)号:EP2121106A2

    公开(公告)日:2009-11-25

    申请号:EP08713332.8

    申请日:2008-01-30

    IPC分类号: A61M31/00 A61F2/24

    摘要: The present invention relates to implantable medical devices and methods that employ these medical devices to treat heart valves. In one embodiment, a medical device (502) is provided comprising a body. The body may have a portion (518) thereof including therapeutic agent (516) and can be configured to support the device proximate a heart valve. Methods in accordance with embodiments of the present invention may also include providing a medical device having a body with at least a portion thereof including a therapeutic agent. These methods may also include positioning the medical device in a location proximate to a downstream surface of the heart valve and securing the device. The therapeutic agent released may then be delivered to the heart valve.

    LOCAL CONTROL OF INFLAMMATION
    9.
    发明公开
    LOCAL CONTROL OF INFLAMMATION 审中-公开
    炎症本地控制

    公开(公告)号:EP1986572A2

    公开(公告)日:2008-11-05

    申请号:EP07710144.2

    申请日:2007-01-16

    IPC分类号: A61F2/06

    摘要: A medical device includes a carrier and an agent. The agent is formulated to control inflammation of biological tissue, such as heart tissue, and is releasably coupled to the carrier. The carrier (130) is configured to be disposed in operative proximity to the biological tissue to be treated by the agent (120). In one embodiment, the carrier is configured to release the agent or otherwise deliver the agent to the biological tissue, thus controlling inflammation of the tissue. Also, a method to improve healing of biological tissue includes placing a medical device proximate to the heart of a patient, where the medical device has a carrier and an agent configured to control inflammation, the agent is releasably coupled to the carrier. In one embodiment, the method includes causing the agent to be released from the carrier.